Obesity associates with mood and anxiety disorders, cognitive dysfunction, and motor decline, whose major causes are puzzling, since obesogenic mechanisms are complex, including a marked intestinal dysbiosis and a sustained metabolic syndrome encompassing hyperglycemia, hyperinsulinemia, systemic inflammation and oxidative stress in both humans and animal models. We addressed whether the changes occurring in mood, cognitive and motor function in diet-induced pre-obese mice are linked to intestinal dysbiosis and body weight gain. Male and female Swiss mice were made pre-obese by feeding with a reinforced high-fat diet for 7 weeks, along which body weight and food intake were monitored. Then, holeboard, stress-induced hyperthermia, footprint, and vertical pole tests were performed to assess cognitive and motor functions. Animals were sacrificed and intestinal dysbiosis assessed: (i) by determining fecal pH and gram positive bacteria counts; (ii) by assessing bacterial infiltration to the jejunum using tissue gram stain; and (iii) by assessing jejunal tissue histopathological changes (H&E) and the immunohistochemical expression of the sustained inflammation marker CXCL10. Average increases in body weight were observed in males (37%) and females (49%), as well as increases in fecal pH, gram positive counts, bacterial infiltration and CXCL10 expression, particularly marked in females. For both sexes, HFD-fed animals with more marked changes in indicators of intestinal dysbiosis also gained weight faster and displayed more marked mood, cognitive and motor alterations. These results suggest that intestinal dysbiosis is a major driver of obesity-like cognitive and motor alterations in pre-obese mice.
| Published in | Journal of Diseases and Medicinal Plants (Volume 2, Issue 3) |
| DOI | 10.11648/j.jdmp.20160203.12 |
| Page(s) | 26-42 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
High-Fat Diet, Pre-obesity, Metabolic Syndrome, Gut Bacteria, Small Intestinal Bacterial Overgrowth, Central Nervous System Functional Alteration
| [1] | Lake, A. A.; Townshend, T.; Alvanides, S.; Stamp, E.; Adamson, A. J. Diet, physical activity, sedentary behaviour and perceptions of the environment in young adults. J. Hum. Nutr. Diet. 2009, 22:444-454. |
| [2] | Wang, Y.; Jahns, L.; Tussing-Humphreys, L.; Xie, B.; Rockett, H.; Liang, H.; Johnson, L. Dietary intake patterns of low-income urban african-american adolescents. J. Am. Diet. Assoc. 2010, 110:1340-1345. |
| [3] | McCarthy, S. Weekly patterns, diet quality and energy balance. Physiol Behav. 2014, 134:55-59. |
| [4] | McElroy, S. L.; Kotwal, R.; Malhotra, S.; Nelson, E. B.; Keck, P. E.; Nemeroff, C. B. Are mood disorders and obesity related? A review for the mental health professional. J. Clin. Psychiatry 2004, 65:634-51, quiz. |
| [5] | Bodenlos, J. S.; Lemon, S. C.; Schneider, K. L.; August, M. A.; Pagoto, S. L. Associations of mood and anxiety disorders with obesity: comparisons by ethnicity. J. Psychosom. Res. 2011, 71:319-324. |
| [6] | Nguyen, J. C.; Killcross, A. S.; Jenkins, T. A. Obesity and cognitive decline: role of inflammation and vascular changes. Front Neurosci. 2014, 8:375. |
| [7] | Miller, A. A.; Spencer, S. J. Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav. Immun. 2014, 42:10-21. |
| [8] | Gentier, I.; D'Hondt, E.; Shultz, S.; Deforche, B.; Augustijn, M.; Hoorne, S.; Verlaecke, K.; De, B., I; Lenoir, M. Fine and gross motor skills differ between healthy-weight and obese children. Res. Dev. Disabil. 2013, 34:4043-4051. |
| [9] | D'Hondt, E.; Deforche, B.; Gentier, I.; Verstuyf, J.; Vaeyens, R.; De, B., I; Philippaerts, R.; Lenoir, M. A longitudinal study of gross motor coordination and weight status in children. Obesity. (Silver. Spring) 2014, 22:1505-1511. |
| [10] | Byard, R. W. Forensic issues at the extremes of weight: From frailty syndrome through frail obesity to morbid obesity. J. Forensic Leg. Med. 2015, 35:38-39. |
| [11] | Mauvais-Jarvis, F. Sex differences in metabolic homeostasis, diabetes, and obesity. Biol. Sex Differ. 2015, 6:14. |
| [12] | Ahima, R. S.; Qi, Y.; Singhal, N. S. Adipokines that link obesity and diabetes to the hypothalamus. Prog. Brain Res. 2006, 153:155-174. |
| [13] | Badman, M. K.; Flier, J. S. The adipocyte as an active participant in energy balance and metabolism. Gastroenterology 2007, 132:2103-2115. |
| [14] | Rummel, C.; Inoue, W.; Poole, S.; Luheshi, G. N. Leptin regulates leukocyte recruitment into the brain following systemic LPS-induced inflammation. Mol. Psychiatry 2010, 15:523-534. |
| [15] | Farooqui, A. A.; Farooqui, T.; Panza, F.; Frisardi, V. Metabolic syndrome as a risk factor for neurological disorders. Cell Mol. Life Sci. 2012, 69:741-762. |
| [16] | Shawcross, D. L. Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy? Expert. Rev. Gastroenterol. Hepatol. 2015, 9:539-542. |
| [17] | Parekh, P. J.; Balart, L. A.; Johnson, D. A. The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. Clin. Transl. Gastroenterol. 2015, 6:e91. |
| [18] | Anhe, F. F.; Varin, T. V.; Le, B. M.; Desjardins, Y.; Levy, E.; Roy, D.; Marette, A. Gut Microbiota Dysbiosis in Obesity-Linked Metabolic Diseases and Prebiotic Potential of Polyphenol-Rich Extracts. Curr. Obes. Rep. 2015. |
| [19] | Ussar, S.; Griffin, N. W.; Bezy, O.; Fujisaka, S.; Vienberg, S.; Softic, S.; Deng, L.; Bry, L.; Gordon, J. I.; Kahn, C. R. Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome. Cell Metab 2015, 22:516-530. |
| [20] | Marteau, P.; Chaput, U. Bacteria as trigger for chronic gastrointestinal disorders. Dig. Dis. 2011, 29:166-171. |
| [21] | Underwood, M. A. Intestinal dysbiosis: novel mechanisms by which gut microbes trigger and prevent disease. Prev. Med. 2014, 65:133-137. |
| [22] | Bleich, A.; Fox, J. G. The Mammalian Microbiome and Its Importance in Laboratory Animal Research. ILAR. J. 2015, 56:153-158. |
| [23] | Marchesi, J. R.; Adams, D. H.; Fava, F.; Hermes, G. D.; Hirschfield, G. M.; Hold, G.; Quraishi, M. N.; Kinross, J.; Smidt, H.; Tuohy, K. M.; Thomas, L. V.; Zoetendal, E. G.; Hart, A. The gut microbiota and host health: a new clinical frontier. Gut 2015. |
| [24] | Mehal, W. Z. The Gordian Knot of dysbiosis, obesity and NAFLD. Nat. Rev. Gastroenterol. Hepatol. 2013, 10:637-644. |
| [25] | Serino, M.; Blasco-Baque, V.; Nicolas, S.; Burcelin, R. Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences. Curr. Cardiol. Rep. 2014, 16:540. |
| [26] | Castanon, N.; Luheshi, G.; Laye, S. Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity. Front Neurosci. 2015, 9:229. |
| [27] | Gorky, J.; Schwaber, J. The role of the gut-brain axis in alcohol use disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2015. |
| [28] | Logan, A. C. Dysbiotic drift: mental health, environmental grey space, and microbiota. J. Physiol Anthropol. 2015, 34:23. |
| [29] | Bienenstock, J.; Kunze, W.; Forsythe, P. Microbiota and the gut-brain axis. Nutr. Rev. 2015, 73 Suppl 1:28-31. |
| [30] | van Esterik, J. C.; Dolle, M. E.; Lamoree, M. H.; van Leeuwen, S. P.; Hamers, T.; Legler, J.; van der Ven, L. T. Programming of metabolic effects in C57BL/6JxFVB mice by exposure to bisphenol A during gestation and lactation. Toxicology 2014, 321:40-52. |
| [31] | Kim, E.; Kim, E. J.; Seo, S. W.; Hur, C. G.; McGregor, R. A.; Choi, M. S. Meta-review of protein network regulating obesity between validated obesity candidate genes in the white adipose tissue of high-fat diet-induced obese C57BL/6J mice. Crit Rev. Food Sci. Nutr. 2014, 54:910-923. |
| [32] | Katsiki, N.; Mikhailidis, D. P. Emerging Vascular Risk Factors in Women: any differences from men? Curr. Med. Chem. 2015. |
| [33] | Nakamura, A.; Terauchi, Y. Lessons from mouse models of high-fat diet-induced NAFLD. Int. J. Mol. Sci. 2013, 14:21240-21257. |
| [34] | Morselli, E.; Frank, A. P.; Palmer, B. F.; Rodriguez-Navas, C.; Criollo, A.; Clegg, D. J. A sexually dimorphic hypothalamic response to chronic high-fat diet consumption. Int. J. Obes. (Lond) 2015. |
| [35] | Carter, R.; Mouralidarane, A.; Soeda, J.; Ray, S.; Pombo, J.; Saraswati, R.; Novelli, M.; Fusai, G.; Rappa, F.; Saracino, C.; Pazienza, V.; Poston, L.; Taylor, P. D.; Vinciguerra, M.; Oben, J. A. Non-alcoholic fatty pancreas disease pathogenesis: a role for developmental programming and altered circadian rhythms. PLoS. One. 2014, 9:e89505. |
| [36] | Blackmore, H. L.; Niu, Y.; Fernandez-Twinn, D. S.; Tarry-Adkins, J. L.; Giussani, D. A.; Ozanne, S. E. Maternal diet-induced obesity programs cardiovascular dysfunction in adult male mouse offspring independent of current body weight. Endocrinology 2014, 155:3970-3980. |
| [37] | De Winther, M. P.; Gijbels, M. J.; Van Dijk, K. W.; Havekes, L. M.; Hofker, M. H. Transgenic mouse models to study the role of the macrophage scavenger receptor class A in atherosclerosis. Int. J. Tissue React. 2000, 22:85-91. |
| [38] | Doggrell, S. Do peroxisome proliferation receptor-gamma antagonists have clinical potential as combined antiobesity and antidiabetic drugs? Expert. Opin. Investig. Drugs 2003, 12:713-716. |
| [39] | Hirotani, Y.; Ozaki, N.; Tsuji, Y.; Urashima, Y.; Myotoku, M. Effects of eicosapentaenoic acid on hepatic dyslipidemia and oxidative stress in high fat diet-induced steatosis. Int. J. Food Sci. Nutr. 2015, 66:569-573. |
| [40] | Shi, L. L.; Li, Y.; Wang, Y.; Feng, Y. MDG-1, an Ophiopogon polysaccharide, regulate gut microbiota in high-fat diet-induced obese C57BL/6 mice. Int. J. Biol. Macromol. 2015, 81:576-583. |
| [41] | Portaluppi, F.; Smolensky, M. H.; Touitou, Y. Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 2010, 27:1911-1929. |
| [42] | Brown, G. R.; Nemes, C. The exploratory behaviour of rats in the hole-board apparatus: is head-dipping a valid measure of neophilia? Behav. Processes 2008, 78:442-448. |
| [43] | Lamprea, M. R.; Cardenas, F. P.; Setem, J.; Morato, S. Thigmotactic responses in an open-field. Braz. J. Med. Biol. Res. 2008, 41:135-140. |
| [44] | Van der Heyden, J. A.; Zethof, T. J.; Olivier, B. Stress-induced hyperthermia in singly housed mice. Physiol Behav. 1997, 62:463-470. |
| [45] | Olivier, B.; Zethof, T.; Pattij, T.; van, B. M.; van, O. R.; Leahy, C.; Oosting, R.; Bouwknecht, A.; Veening, J.; van der Gugten, J.; Groenink, L. Stress-induced hyperthermia and anxiety: pharmacological validation. Eur. J. Pharmacol. 2003, 463:117-132. |
| [46] | Adriaan, B. J.; Olivier, B.; Paylor, R. E. The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: a review of pharmacological and genetic studies in the mouse. Neurosci. Biobehav. Rev. 2007, 31:41-59. |
| [47] | Vinkers, C. H.; van Bogaert, M. J.; Klanker, M.; Korte, S. M.; Oosting, R.; Hanania, T.; Hopkins, S. C.; Olivier, B.; Groenink, L. Translational aspects of pharmacological research into anxiety disorders: the stress-induced hyperthermia (SIH) paradigm. Eur. J. Pharmacol. 2008, 585:407-425. |
| [48] | Groenink, L.; Vinkers, C.; van, O. R.; Olivier, B. Models of anxiety: stress-induced hyperthermia (SIH) in singly housed mice. Curr. Protoc. Pharmacol. 2009, Chapter 5:Unit. |
| [49] | Wieronska, J. M.; Stachowicz, K.; Branski, P.; Palucha-Poniewiera, A.; Pilc, A. On the mechanism of anti-hyperthermic effects of LY379268 and LY487379, group II mGlu receptors activators, in the stress-induced hyperthermia in singly housed mice. Neuropharmacology 2012, 62:322-331. |
| [50] | Kistemaker, J. A.; Den Hartog, E. A.; Daanen, H. A. Reliability of an infrared forehead skin thermometer for core temperature measurements. J. Med. Eng Technol. 2006, 30:252-261. |
| [51] | Hishimura, Y.; Itoh, K. Effect of social interaction on skin temperature in mice. Shinrigaku Kenkyu 2009, 80:152-158. |
| [52] | Bach, A. J.; Stewart, I. B.; Minett, G. M.; Costello, J. T. Does the technique employed for skin temperature assessment alter outcomes? A systematic review. Physiol Meas. 2015, 36:R27-R51. |
| [53] | Ansley, L.; Marvin, G.; Sharma, A.; Kendall, M. J.; Jones, D. A.; Bridge, M. W. The effects of head cooling on endurance and neuroendocrine responses to exercise in warm conditions. Physiol Res. 2008, 57:863-872. |
| [54] | Schlader, Z. J.; Perry, B. G.; Jusoh, M. R.; Hodges, L. D.; Stannard, S. R.; Mundel, T. Human temperature regulation when given the opportunity to behave. Eur. J. Appl. Physiol 2013, 113:1291-1301. |
| [55] | Paylor, R.; Nguyen, M.; Crawley, J. N.; Patrick, J.; Beaudet, A.; Orr-Urtreger, A. Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn. Mem. 1998, 5:302-316. |
| [56] | Bouet, V.; Freret, T.; Toutain, J.; Divoux, D.; Boulouard, M.; Schumann-Bard, P. Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp. Neurol. 2007, 203:555-567. |
| [57] | Carter, R. J.; Lione, L. A.; Humby, T.; Mangiarini, L.; Mahal, A.; Bates, G. P.; Dunnett, S. B.; Morton, A. J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 1999, 19:3248-3257. |
| [58] | Simon, P.; Dupuis, R.; Costentin, J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav. Brain Res. 1994, 61:59-64. |
| [59] | Depino, A. M.; Gross, C. Simultaneous assessment of autonomic function and anxiety-related behavior in BALB/c and C57BL/6 mice. Behav. Brain Res. 2007, 177:254-260. |
| [60] | Yan, W. J.; Mu, Y.; Yu, N.; Yi, T. L.; Zhang, Y.; Pang, X. L.; Cheng, D.; Yang, J. Protective effects of metformin on reproductive function in obese male rats induced by high-fat diet. J. Assist. Reprod. Genet. 2015, 32:1097-1104. |
| [61] | Scalera, A.; Di Minno, M. N.; Tarantino, G. What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J. Gastroenterol. 2013, 19:5402-5420. |
| [62] | Riddiford-Harland, D. L.; Steele, J. R.; Storlien, L. H. Does obesity influence foot structure in prepubescent children? Int. J. Obes. Relat Metab Disord. 2000, 24:541-544. |
| [63] | Sarkar, A.; Singh, M.; Bansal, N.; Kapoor, S. Effects of obesity on balance and gait alterations in young adults. Indian J. Physiol Pharmacol. 2011, 55:227-233. |
| [64] | Valles, A.; Boender, A. J.; Gijsbers, S.; Haast, R. A.; Martens, G. J.; de, W. P. Genomewide analysis of rat barrel cortex reveals time- and layer-specific mRNA expression changes related to experience-dependent plasticity. J. Neurosci. 2011, 31:6140-6158. |
| [65] | d'Isa, R.; Brambilla, R.; Fasano, S. Behavioral methods for the study of the Ras-ERK pathway in memory formation and consolidation: passive avoidance and novel object recognition tests. Methods Mol. Biol. 2014, 1120:131-156. |
| [66] | Gobbo, O. L.; O'Mara, S. M. Impact of enriched-environment housing on brain-derived neurotrophic factor and on cognitive performance after a transient global ischemia. Behav. Brain Res. 2004, 152:231-241. |
| [67] | Vaseghi, G.; Rabbani, M.; Hajhashemi, V. The CB(1) receptor antagonist, AM281, improves recognition loss induced by naloxone in morphine withdrawal mice. Basic Clin. Pharmacol. Toxicol. 2012, 111:161-165. |
| [68] | Amar, S.; Zhou, Q.; Shaik-Dasthagirisaheb, Y.; Leeman, S. Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc. Natl. Acad. Sci. U. S. A 2007, 104:20466-20471. |
| [69] | Andre, C.; Dinel, A. L.; Ferreira, G.; Laye, S.; Castanon, N. Diet-induced obesity progressively alters cognition, anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior: focus on brain indoleamine 2,3-dioxygenase activation. Brain Behav. Immun. 2014, 41:10-21. |
| [70] | Crescioli, C. Chemokines and transplant outcome. Clin. Biochem. 2015. |
| [71] | Van Raemdonck, K.; Van den Steen, P. E.; Liekens, S.; Van Damme, J.; Struyf, S. CXCR3 ligands in disease and therapy. Cytokine Growth Factor Rev. 2015, 26:311-327. |
| [72] | Helajarvi, H.; Pahkala, K.; Heinonen, O. J.; Juonala, M.; Oikonen, M.; Tammelin, T.; Hutri-Kahonen, N.; Kahonen, M.; Lehtimaki, T.; Mikkila, V.; Viikari, J.; Raitakari, O. T. Television viewing and fatty liver in early midlife. The Cardiovascular Risk in Young Finns Study. Ann. Med. 2015:1-8. |
| [73] | Fabbrini, E.; Tiemann, L. C.; Love-Gregory, L.; Okunade, A. L.; Yoshino, M.; Fraterrigo, G.; Patterson, B. W.; Klein, S. Physiological Mechanisms of Weight-gain Induced Steatosis in People with Obesity. Gastroenterology 2015. |
| [74] | Bottino, C.; Vazquez, M.; Devesa, V.; Laforenza, U. Impaired aquaporins expression in the gastrointestinal tract of rat after mercury exposure. J. Appl. Toxicol. 2015. |
APA Style
Paul F. Seke Etet, Fayez K. Alharbi, Sayed Y. Osman, Rejo Jacob Joseph, Yahia M. Bushara, et al. (2016). Gut Dysbiosis Clinical Indicators Associate with Body Weight Gain and Cognitive Dysfunction in High-Fat Diet-Induced Pre-obese Mice. Journal of Diseases and Medicinal Plants, 2(3), 26-42. https://doi.org/10.11648/j.jdmp.20160203.12
ACS Style
Paul F. Seke Etet; Fayez K. Alharbi; Sayed Y. Osman; Rejo Jacob Joseph; Yahia M. Bushara, et al. Gut Dysbiosis Clinical Indicators Associate with Body Weight Gain and Cognitive Dysfunction in High-Fat Diet-Induced Pre-obese Mice. J. Dis. Med. Plants 2016, 2(3), 26-42. doi: 10.11648/j.jdmp.20160203.12
AMA Style
Paul F. Seke Etet, Fayez K. Alharbi, Sayed Y. Osman, Rejo Jacob Joseph, Yahia M. Bushara, et al. Gut Dysbiosis Clinical Indicators Associate with Body Weight Gain and Cognitive Dysfunction in High-Fat Diet-Induced Pre-obese Mice. J Dis Med Plants. 2016;2(3):26-42. doi: 10.11648/j.jdmp.20160203.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.jdmp.20160203.12,
author = {Paul F. Seke Etet and Fayez K. Alharbi and Sayed Y. Osman and Rejo Jacob Joseph and Yahia M. Bushara and Lorella Vecchio and John C. Chijuka and Shama I. Y. Adam and Elhassan M. A. Saeed and Mohammed Farahna},
title = {Gut Dysbiosis Clinical Indicators Associate with Body Weight Gain and Cognitive Dysfunction in High-Fat Diet-Induced Pre-obese Mice},
journal = {Journal of Diseases and Medicinal Plants},
volume = {2},
number = {3},
pages = {26-42},
doi = {10.11648/j.jdmp.20160203.12},
url = {https://doi.org/10.11648/j.jdmp.20160203.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jdmp.20160203.12},
abstract = {Obesity associates with mood and anxiety disorders, cognitive dysfunction, and motor decline, whose major causes are puzzling, since obesogenic mechanisms are complex, including a marked intestinal dysbiosis and a sustained metabolic syndrome encompassing hyperglycemia, hyperinsulinemia, systemic inflammation and oxidative stress in both humans and animal models. We addressed whether the changes occurring in mood, cognitive and motor function in diet-induced pre-obese mice are linked to intestinal dysbiosis and body weight gain. Male and female Swiss mice were made pre-obese by feeding with a reinforced high-fat diet for 7 weeks, along which body weight and food intake were monitored. Then, holeboard, stress-induced hyperthermia, footprint, and vertical pole tests were performed to assess cognitive and motor functions. Animals were sacrificed and intestinal dysbiosis assessed: (i) by determining fecal pH and gram positive bacteria counts; (ii) by assessing bacterial infiltration to the jejunum using tissue gram stain; and (iii) by assessing jejunal tissue histopathological changes (H&E) and the immunohistochemical expression of the sustained inflammation marker CXCL10. Average increases in body weight were observed in males (37%) and females (49%), as well as increases in fecal pH, gram positive counts, bacterial infiltration and CXCL10 expression, particularly marked in females. For both sexes, HFD-fed animals with more marked changes in indicators of intestinal dysbiosis also gained weight faster and displayed more marked mood, cognitive and motor alterations. These results suggest that intestinal dysbiosis is a major driver of obesity-like cognitive and motor alterations in pre-obese mice.},
year = {2016}
}
TY - JOUR T1 - Gut Dysbiosis Clinical Indicators Associate with Body Weight Gain and Cognitive Dysfunction in High-Fat Diet-Induced Pre-obese Mice AU - Paul F. Seke Etet AU - Fayez K. Alharbi AU - Sayed Y. Osman AU - Rejo Jacob Joseph AU - Yahia M. Bushara AU - Lorella Vecchio AU - John C. Chijuka AU - Shama I. Y. Adam AU - Elhassan M. A. Saeed AU - Mohammed Farahna Y1 - 2016/06/16 PY - 2016 N1 - https://doi.org/10.11648/j.jdmp.20160203.12 DO - 10.11648/j.jdmp.20160203.12 T2 - Journal of Diseases and Medicinal Plants JF - Journal of Diseases and Medicinal Plants JO - Journal of Diseases and Medicinal Plants SP - 26 EP - 42 PB - Science Publishing Group SN - 2469-8210 UR - https://doi.org/10.11648/j.jdmp.20160203.12 AB - Obesity associates with mood and anxiety disorders, cognitive dysfunction, and motor decline, whose major causes are puzzling, since obesogenic mechanisms are complex, including a marked intestinal dysbiosis and a sustained metabolic syndrome encompassing hyperglycemia, hyperinsulinemia, systemic inflammation and oxidative stress in both humans and animal models. We addressed whether the changes occurring in mood, cognitive and motor function in diet-induced pre-obese mice are linked to intestinal dysbiosis and body weight gain. Male and female Swiss mice were made pre-obese by feeding with a reinforced high-fat diet for 7 weeks, along which body weight and food intake were monitored. Then, holeboard, stress-induced hyperthermia, footprint, and vertical pole tests were performed to assess cognitive and motor functions. Animals were sacrificed and intestinal dysbiosis assessed: (i) by determining fecal pH and gram positive bacteria counts; (ii) by assessing bacterial infiltration to the jejunum using tissue gram stain; and (iii) by assessing jejunal tissue histopathological changes (H&E) and the immunohistochemical expression of the sustained inflammation marker CXCL10. Average increases in body weight were observed in males (37%) and females (49%), as well as increases in fecal pH, gram positive counts, bacterial infiltration and CXCL10 expression, particularly marked in females. For both sexes, HFD-fed animals with more marked changes in indicators of intestinal dysbiosis also gained weight faster and displayed more marked mood, cognitive and motor alterations. These results suggest that intestinal dysbiosis is a major driver of obesity-like cognitive and motor alterations in pre-obese mice. VL - 2 IS - 3 ER -
Information
Email: